NCT03786978View on ClinicalTrials.gov

Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 9, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

January 30, 2018

Conditions
Diabetes Mellitus
Interventions
BEHAVIORAL

Structured pharmaceutical care

Patients receive a structured pharmaceutical care from one year after basal hospital discharge

BEHAVIORAL

Comparator

Patient received a single phone call 30 days after basal hospital discharge.

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus | Biotech Hunter | Biotech Hunter